From: The usefulness of 18F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD)
Region-based analysis
Diagnostic performance
TP
FP
TN
FN
Total
Sensitivity
Specificity
Accuracy
FDG-PET/CT
83
6
226
9
324
83/92 (90.2Â %)
226/232 (97.4Â %)
309/324 (95.4Â %)
CT
55
12
220
37
55/2 (59.8Â %)
220/232 (94.8Â %)
275/324 (84.9Â %)